BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 9870499)

  • 1. Heparin-induced thrombocytopenia (HIT) and thrombosis in a haemodialysis-dependent patient with systemic vasculitis.
    Roe SD; Cassidy MJ; Haynes AP; Byrne JL
    Nephrol Dial Transplant; 1998 Dec; 13(12):3226-9. PubMed ID: 9870499
    [No Abstract]   [Full Text] [Related]  

  • 2. [Successful lysis therapy of inferior vena cava and iliofemoral venous thrombosis in heparin-induced thrombocytopenia type II].
    Fischer KG
    Dtsch Med Wochenschr; 1999 Jan; 124(1-2):32-3. PubMed ID: 9951458
    [No Abstract]   [Full Text] [Related]  

  • 3. [Value of orgaran in hemodialysis during heparin-induced thrombopenia].
    Lamriben L; Tiberghien F; Delacour JL; Floriot C; Wagschal G; Daoudal P; Ory JP
    Presse Med; 1996 Sep; 25(28):1303. PubMed ID: 8949796
    [No Abstract]   [Full Text] [Related]  

  • 4. Repeated premature hemofilter clotting during regional citrate anticoagulation as indicator of heparin induced thrombocytopenia.
    Lehner GF; Schöpf M; Harler U; Pechlaner C; Joannidis M
    Blood Purif; 2014; 38(2):127-30. PubMed ID: 25412655
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Heparin-induced thrombocytopaenia complicated by arterial and venous thrombosis: report of 2 cases successfully treated by a danaparoid sodium.
    Darling K; Jaumotte C; Saussoy P; Zech F; Lavenne E; Hainaut P
    Acta Clin Belg; 2000; 55(3):176-81. PubMed ID: 10981327
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cardiopulmonary bypass and heparin-induced thrombocytopenia: pitfalls of anticoagulation with danaparoid.
    Kanagasabay R; Unsworth-White MJ; Farnsworth G; Haxby EJ; Smith EE
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):428-9. PubMed ID: 10917979
    [No Abstract]   [Full Text] [Related]  

  • 7. Use of danaparoid during cardiopulmonary bypass in patients with heparin-induced thrombocytopenia.
    Olin DA; Urdaneta F; Lobato EB
    J Cardiothorac Vasc Anesth; 2000 Dec; 14(6):707-9. PubMed ID: 11139115
    [No Abstract]   [Full Text] [Related]  

  • 8. Heparin-induced thrombocytopenia type II: perioperative management using danaparoid in a coronary artery bypass patient with renal failure.
    Westphal K; Martens S; Strouhal U; Matheis G; Lindhoff-Last E; Wimmer-Greinecker G; Lischke V
    Thorac Cardiovasc Surg; 1997 Dec; 45(6):318-20. PubMed ID: 9477469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk of thrombosis in patients with malignancy and heparin-induced thrombocytopenia.
    Opatrny L; Warner MN
    Am J Hematol; 2004 Jul; 76(3):240-4. PubMed ID: 15224359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Heparin-induced thrombocytopenia in hemodialysis patients.
    Brouwer DJ; Peterson P
    Nephrol Nurs J; 2000 Apr; 27(2):240-1, 213. PubMed ID: 11111553
    [No Abstract]   [Full Text] [Related]  

  • 11. Venous thromboembolism in heparin-induced thrombocytopenia.
    Warkentin TE
    Curr Opin Pulm Med; 2000 Jul; 6(4):343-51. PubMed ID: 10912644
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cerebral venous thrombosis due to essential thrombocythemia and worsened by heparin-induced thrombocytopenia and thrombosis.
    Richard S; Perrin J; Lavandier K; Lacour JC; Ducrocq X
    Platelets; 2011; 22(2):157-9. PubMed ID: 21142409
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thrombosis and hemorrhage in heparin-induced thrombocytopenia in seriously ill patients.
    Wester JP; Haas FJ; Biesma DH; Leusink JA; Veth G
    Intensive Care Med; 2004 Oct; 30(10):1927-34. PubMed ID: 15156309
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Treatment of heparin-induced thrombocytopenia.
    Peters FP
    J Thorac Cardiovasc Surg; 1997 Sep; 114(3):517-8. PubMed ID: 9305220
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical experience with Danaparoid-sodium: measures to be taken in heparin-induced thrombocytopenia].
    Chirurg; 1998 Nov; 69(11 Suppl Massnahme):1-4. PubMed ID: 9853175
    [No Abstract]   [Full Text] [Related]  

  • 16. [Clinical experiences with Danaparoid sodium. Measures to be taken in heparin-induced thrombocytopenia].
    Anaesthesist; 1998 Nov; 47(11 Suppl Massnahmen):1-4. PubMed ID: 9884734
    [No Abstract]   [Full Text] [Related]  

  • 17. Failure of danaparoid anticoagulation for cardiopulmonary bypass.
    Ariano RE; Bhattacharya SK; Moon M; Brownell LG
    J Thorac Cardiovasc Surg; 2000 Jan; 119(1):167-8. PubMed ID: 10612777
    [No Abstract]   [Full Text] [Related]  

  • 18. Danaparoid thromboprophylaxis in pregnant women with heparin-induced thrombocytopenia.
    Woo YL; Allard S; Cohen H; Letsky E; de Swiet M
    BJOG; 2002 Apr; 109(4):466-8. PubMed ID: 12013171
    [No Abstract]   [Full Text] [Related]  

  • 19. Danaparoid use for haemodialysis in a morbidly obese patient with heparin-induced thrombocytopenia - Need for a higher than recommended weight-based dosing.
    Castelino RL; Maddula M; Tarafdar S; Sud K; Kairaitis L
    Thromb Res; 2019 Aug; 180():70-73. PubMed ID: 31229923
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Sinus thrombosis in heparin-induced thrombocytopenia type II].
    Schill D
    Med Monatsschr Pharm; 2005 Jul; 28(7):253-4. PubMed ID: 16038130
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 9.